Compared to conventional methods, SMRT technology detected more abnormal hemoglobin variant sites on the HBA1, HBA2, and HBB genes, which illustrated the value of SMRT technology in the diagnosis of common and rare types of α-thalassemia and β-thalassemia variants. This evidence concerns the gene HBB and thalassemia.